FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320730844> ?p ?o ?g. }

• W4320730844 endingPage "100235" @default.
• W4320730844 startingPage "100235" @default.
• W4320730844 abstract "The development of diabetes mellitus (DM) in patients taking integrase strand transfer inhibitors (INSTIs) has raised concerns. It's critical because, in most guidelines, INSTIs are the preferred third agent at first-line regimens. This study investigates the excess risk of developing DM among people living with HIV (PWH) on INSTIs-based regimens compared to those with other combination antiretroviral therapies (cART). A search from PubMed, clinicaltrials.gov, Latin America and Caribbean health sciences literature, Cochrane, and google scholar to retrieve case-control and cohort studies were done. The literature search was performed for studies from January 2007 to January 2021. Data were extracted from studies and pooled as risk ratios (RR) with a 95% confidence interval (CI) using Stata 14 software. The protocol was registered in PROSPERO, ID: CRD42021230282. This review included ten studies, resulting in 62 400 participants. There was no significant difference in the incidence of DM between participants receiving INSTIs-based regimens versus other cARTs (RR 0.97, 95% CI: 0.92–1.03; participants = 50 958; studies = 4; I2 = 86.8%, chi-square = 22.67). There is no statistically significant difference in DM among people treated with INSTIs-based regimens compared to those treated with boosted protease inhibitors (PIs)-based regimens (RR 0.97, 95% CI 0.92–1.03; participants = 49 840; studies = 3; I2 = 89.3%, chi-square = 18.65). DM incidence was lower in INSTIs-based regimens than in those using non-nucleoside reverse transcriptase inhibitors (NNRTIs)-based regimens (RR 0.80, 95% CI 0.69–0.91; participants = 42 346; studies = 2; I2 = 0%, chi-square = 0.18). The present review shows a nonsignificant difference in the incidence of DM in patients receiving INSTIs-based regimens compared to other regimens. However, there was a lower incidence of DM in the INSTIs group compared to the NNRTIs-based and PIs compared to the NNRTIs-based. When the INSTIs drugs dolutegravir, raltegravir, and elvitegravir were compared, there was a lower incidence of DM in raltegravir compared with elvitegravir." @default.
• W4320730844 created "2023-02-15" @default.
• W4320730844 creator A5043670206 @default.
• W4320730844 creator A5057599684 @default.
• W4320730844 creator A5082702781 @default.
• W4320730844 date "2023-03-01" @default.
• W4320730844 modified "2023-10-13" @default.
• W4320730844 title "New onset type 2 diabetes mellitus risks with integrase strand transfer inhibitors-based regimens: A systematic review and meta-analysis" @default.
• W4320730844 cites W1971428964 @default.
• W4320730844 cites W1995497236 @default.
• W4320730844 cites W2013541138 @default.
• W4320730844 cites W2022456886 @default.
• W4320730844 cites W2047040270 @default.
• W4320730844 cites W2047542844 @default.
• W4320730844 cites W2082697314 @default.
• W4320730844 cites W2118362719 @default.
• W4320730844 cites W2168211801 @default.
• W4320730844 cites W2169205464 @default.
• W4320730844 cites W2185461071 @default.
• W4320730844 cites W2313892069 @default.
• W4320730844 cites W2410236217 @default.
• W4320730844 cites W2491572170 @default.
• W4320730844 cites W2502338363 @default.
• W4320730844 cites W2746644771 @default.
• W4320730844 cites W2758369103 @default.
• W4320730844 cites W2766138644 @default.
• W4320730844 cites W2769207084 @default.
• W4320730844 cites W2795476651 @default.
• W4320730844 cites W2908435396 @default.
• W4320730844 cites W2913548118 @default.
• W4320730844 cites W2945762579 @default.
• W4320730844 cites W2945985905 @default.
• W4320730844 cites W2955538893 @default.
• W4320730844 cites W2969556335 @default.
• W4320730844 cites W2969635519 @default.
• W4320730844 cites W2979627107 @default.
• W4320730844 cites W3006965005 @default.
• W4320730844 cites W3009549607 @default.
• W4320730844 cites W3010683061 @default.
• W4320730844 cites W3046474211 @default.
• W4320730844 cites W3049690047 @default.
• W4320730844 cites W3087354066 @default.
• W4320730844 cites W3093005905 @default.
• W4320730844 cites W3116536567 @default.
• W4320730844 cites W3143367749 @default.
• W4320730844 cites W3153233221 @default.
• W4320730844 cites W3208818910 @default.
• W4320730844 cites W4210795835 @default.
• W4320730844 cites W4229027222 @default.
• W4320730844 cites W4250056697 @default.
• W4320730844 cites W3092321959 @default.
• W4320730844 doi "https://doi.org/10.1016/j.metop.2023.100235" @default.
• W4320730844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36923992" @default.
• W4320730844 hasPublicationYear "2023" @default.
• W4320730844 type Work @default.
• W4320730844 citedByCount "6" @default.
• W4320730844 countsByYear W43207308442023 @default.
• W4320730844 crossrefType "journal-article" @default.
• W4320730844 hasAuthorship W4320730844A5043670206 @default.
• W4320730844 hasAuthorship W4320730844A5057599684 @default.
• W4320730844 hasAuthorship W4320730844A5082702781 @default.
• W4320730844 hasBestOaLocation W43207308441 @default.
• W4320730844 hasConcept C120665830 @default.
• W4320730844 hasConcept C121332964 @default.
• W4320730844 hasConcept C126322002 @default.
• W4320730844 hasConcept C14430832 @default.
• W4320730844 hasConcept C159047783 @default.
• W4320730844 hasConcept C3013748606 @default.
• W4320730844 hasConcept C44249647 @default.
• W4320730844 hasConcept C61511704 @default.
• W4320730844 hasConcept C71924100 @default.
• W4320730844 hasConcept C82789193 @default.
• W4320730844 hasConcept C95190672 @default.
• W4320730844 hasConceptScore W4320730844C120665830 @default.
• W4320730844 hasConceptScore W4320730844C121332964 @default.
• W4320730844 hasConceptScore W4320730844C126322002 @default.
• W4320730844 hasConceptScore W4320730844C14430832 @default.
• W4320730844 hasConceptScore W4320730844C159047783 @default.
• W4320730844 hasConceptScore W4320730844C3013748606 @default.
• W4320730844 hasConceptScore W4320730844C44249647 @default.
• W4320730844 hasConceptScore W4320730844C61511704 @default.
• W4320730844 hasConceptScore W4320730844C71924100 @default.
• W4320730844 hasConceptScore W4320730844C82789193 @default.
• W4320730844 hasConceptScore W4320730844C95190672 @default.
• W4320730844 hasLocation W43207308441 @default.
• W4320730844 hasLocation W43207308442 @default.
• W4320730844 hasLocation W43207308443 @default.
• W4320730844 hasOpenAccess W4320730844 @default.
• W4320730844 hasPrimaryLocation W43207308441 @default.
• W4320730844 hasRelatedWork W1539974851 @default.
• W4320730844 hasRelatedWork W2057222603 @default.
• W4320730844 hasRelatedWork W2077861249 @default.
• W4320730844 hasRelatedWork W2083188054 @default.
• W4320730844 hasRelatedWork W2253664354 @default.
• W4320730844 hasRelatedWork W2375449733 @default.
• W4320730844 hasRelatedWork W2385936183 @default.
• W4320730844 hasRelatedWork W2939697310 @default.
• W4320730844 hasRelatedWork W3217030500 @default.

• next